Multisite Evaluation and Validation of a Sensitive Diagnostic and Screening System for Spinal Muscular Atrophy that Reports SMN1 and SMN2 Copy Number, along with Disease Modifier and Gene Duplication Variants

: Milligan John N, Larson Jessica L, Filipovic-Sadic Stella, Laosinchai-Wolf Walairat, Huang Ya-Wen, Ko Tsang-Ming, Abbott Kristin M, Lemmink Henny H, Toivonen Minna, Schleutker Johanna, Gentile Caren, Van Deerlin Vivianna M, Zhu Huiping, Latham Gary J

Publisher: ELSEVIER SCIENCE INC

: 2021

: Journal of Molecular Diagnostics

: JOURNAL OF MOLECULAR DIAGNOSTICS

: J MOL DIAGN

: 23

: 6

: 753

: 764

: 12

: 1525-1578

: 1943-7811

DOI: https://doi.org/10.1016/j.jmoldx.2021.03.004

: https://pure.rug.nl/ws/files/197336777/1_s2.0_S1525157821000696_main.pdf

Spinal muscular atrophy is a severe autosomal recessive disease caused by disruptions in the SMN1 gene. The nearly identical SMN2 gene copy number is associated with disease severity. SMN1 duplication markers, such as c.*3+80T>G and c.*211_*212del, can assess residual carrier risk. An SMN2 disease modifier (c.859G>C) can help inform prognostic outcomes. The emergence of multiple precision gene therapies for spinal muscular atrophy requires accurate and rapid detection of SMN1 and SMN2 copy numbers to enable early treatment and optimal patient outcomes. We developed and evaluated a singletube PCR/capillary electrophoresis assay system that quantifies SMN1/2 copy numbers and genotypes three additional clinically relevant variants. Analytical validation was performed with human cell lines and whole blood representing varying SMN1/2 copies on four capillary electrophoresis instrument models. In addition, four independent laboratories used the assay to test 468 residual clinical genomic DNA samples. The results were >98.3% concordant with consensus SMN1/2 exon 7 copy numbers, determined using multiplex ligation-dependent probe amplification and droplet digital PCR, and were 100% concordant with Sanger sequencing for the three variants. Furthermore, copy number values were 98.6% (SMN1) and 97.1% (SMN2) concordant to each laboratory's own reference results. (J Mol Diagn